The Principles of Clinical Cytogenetics - Extra Materials - Springer

Cytogenetics of Hematologic Neoplasms 417
199. Virgilio, L., Narducci, M.G., Isobe, M., et al. (1994) Identification of the TCL1 gene involved in T-cell malignancies.
Proc. Natl. Acad. Sci. USA 91, 12,530–12,534.
200. Pekarsky, Y., Hallas, C., Isobe, M., Russo, G., and Croce, C.M. (1999). Abnormalities at 14q32.1 in T-cell malignancies
involve two oncogenes. Proc. Natl. Acad. Sci. USA 96, 2949–2951.
201. Herbert, G.B., Shi, B., and Gartenhaus, R.B. (2001) Expression and stabilization of the MCT-1 protein by DNA damaging
agents. Oncogene 20, 6777–6783.
202. Stilgenbauer, S., Schaffner, C., Litterst, A., et al. (1997) Biallelic mutations in the ATM gene in T-prolymphocytic
leukemia. Nature Med. 3, 1155–1159.
203. Vorechovsky, I., Luo, L., Dyer, M.J., et al. (1997) Clustering of missense mutations in the ataxia-telangiectasia gene in
a sporadic T-cell leukaemia. Nature Genet. 17, 96–99.
204. Sorour, A., Brito-Babapulle, V., Smedley, D., Yuille, M., and Catovsky, D. (2000) Unusual breakpoint distribution of
8p abnormalities in T-prolymphocytic leukemia: a study with YACS mapping to 8p11-p12. Cancer Genet. Cytogenet.
121, 128–132.
205. Hetet, G., Dastot, H., Baens, M., et al. (2000) Recurrent molecular deletion of the 12p13 region, centromeric to ETV6/
TEL, in T-cell prolymphocytic leukemia. Hematol. J. 1, 42–47.
206. Imamura, N., Kusunoki, Y., Kawa-Ha, K., et al. (1990) Aggressive natural killer cell leukaemia/lymphoma: report of
four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of
lymphoid cells. Br. J. Haematol. 75, 49–59.
207. Chan, J.K., Sin, V.C., Wong, K.F., et al. (1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a
clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89, 4501–4513.
208. Chan, J.K. (1998) Natural killer cell neoplasms. Anat. Pathol. 3, 77–145.
209. Wong, K.F., Zhang, Y.M., and Chan, J.K. (1999) Cytogenetic abnormalities in natural killer cell lymphoma/
leukaemia—is there a consistent pattern? Leukemia Lymphoma 34, 241–250.
210. Siu, L.L., Chan, J.K., and Kwong, Y.L. (2002) Natural killer cell malignancies: clinicopathologic and molecular features.
Histol. Histopathol. 17(2), 539–554.
211. Chan, J.K., Yip, T.T., Tsang, W.Y., et al. (1994) Detection of Epstein-Barr viral RNA in malignant lymphomas of the
upper aerodigestive tract. Am. J. Surg. Pathol. 18, 938–946.
212. Arber, D.A., Weiss, L.M., Albujar, P.F., Chen, Y.Y., and Jaffe, E.S. (1993) Nasal lymphomas in Peru. High incidence
of T-cell immunophenotype and Epstein-Barr virus infection. Am. J. Surg. Pathol. 17, 392–399.
213. Elenitoba-Johnson, K.S., Zarate-Osorno, A., Meneses, A., et al. (1998) Cytotoxic granular protein expression, Epstein–
Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell
lymphomas from Mexico. Mod. Pathol. 11, 754–761.
214. Siu, L.L., Wong, K.F., Chan, J.K., and Kwong, Y.L. (1999) Comparative genomic hybridization analysis of natural killer
cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations. Am. J. Pathol. 155, 1419–1425.
215. Ko, Y.H., Choi, K.E., Han, J.H., Kim, J.M., and Ree, H.J. (2001) Comparative genomic hybridization study of nasaltype
NK/T-cell lymphoma. Cytometry 46, 85–91.
216. Willemze, R., Kerl, H., Sterry, W., et al. (1997) EORTC classification for primary cutaneous lymphomas: a proposal
from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
Blood 90, 354–371.
217. Pancake, B.A., Zucker-Franklin, D., and Coutavas, E.E. (1995) The cutaneous T-cell lymphoma, mycosis fungoides, is
a human T-cell lymphotropic virus-associated disease. A study of 50 patients. J. Clin. Invest. 95, 547–554.
218. Ghosh, S.K., Abrams, J.T., Terunuma, H., Vonderheid, E.C., and DeFreitas, E. (1994) Human T-cell leukemia virus
type I tax/rex DNA and RNA in cutaneous T-cell lymphoma. Blood 84, 2663–2671.
219. Ralfkiaer, E. (1991) Malignant lymphomas of true histiocytic origin: a clinical, histological, immunophenotypic and
genotyic study. J. Pathol. 160, 9–17.
220. Bergman, R. (1999) How useful are T-cell receptor gene rearrangement studies as an adjunct to the histopathologic
diagnosis of mycosis fungoides? Am. J. Dermatopathol. 21, 498–502.
221. Navas, I.C., Ortiz-Romero, P.L., Villuendas, R., et al. (2000) p16(INK4a) gene alterations are frequent in lesions of
mycosis fungoides. Am. J. Path. 156, 1565–1572.
222. Mao, X., Lillington, D., Scarisbrick, J.J., et al. (2002) Molecular cytogenetic analysis of cutaneous T-cell lymphomas:
identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br. J. Dermatol. 147, 464–475.
223. Karenko, L., Sarna, S., Kahkonen, M., and Ranki, A. (2003) Chromosomal abnormalities in relation to clinical disease
in patients with cutaneous T-cell lymphoma: a 5-year follow-up study. Br. J. Dermatol. 148, 55–64.
224. Siegert, W., Nerl, C., Agthe, A., et al. (1995) Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma:
prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group.
Ann. Oncol. 6, 659–664.
225. Weiss, L.M., Strickler, J.G., Dorfman, R.F., Horning, S J., Warnke, R.A., and Sklar, J. (1986) Clonal T-cell populations
in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am. J. Pathol.
122, 392–397.
226. O’Connor, N.T., Crick, J.A., Wainscoat, J.S., et al. (1986) Evidence for monoclonal T lymphocyte proliferation in
angioimmunoblastic lymphadenopathy. J. Clin. Pathol. 39, 1229–1232.